Furthermore, tumor heterogeneity and stromal contribution (such as connective tissues, blood vessels and immune infiltrates) and a likely selection bias in the cell lines - which are more ER-negative, mesenchymal, and TP53 mutant than primary tumors - could explain the observed discrepancies. Here, ESR1 is linked to neoplasm.